Ketorolac Baxter

Ketorolac Trometamol, the active ingredient in Ketorolac Baxter, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an injectable solution for intramuscular or intravenous use. It is employed for short‑term management of moderate to severe acute pain, particularly postoperative pain, in adult patients.

GNH USA supplies Ketorolac Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Ketorolac Trometamol is an NSAID used to control pain by reducing inflammation in the prostaglandin pathway.

- Postoperative pain: provides rapid analgesia for patients recovering from surgery. - Acute moderate to severe pain: offers short‑term relief when opioid therapy is not indicated. - Short‑term pain management: limits use to a few days to control intense acute pain episodes.

Ketorolac may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Nausea - Headache - Dizziness - Gastrointestinal discomfort - Injection‑site pain - Elevated blood pressure

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Acute renal impairment - Severe allergic reactions (anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hepatic dysfunction - Cardiovascular thrombotic events

When prescribing Ketorolac, clinicians should consider several safety measures to minimize risk.

- Renal function: assess baseline kidney function and avoid prolonged use in patients with impairment. - Gastrointestinal risk: use with caution in patients with a history of ulcer disease or bleeding. - Cardiovascular status: monitor blood pressure and avoid in patients with uncontrolled hypertension. - Concomitant NSAIDs or anticoagulants: avoid combined use to reduce bleeding risk. - Pregnancy and lactation: avoid unless benefits outweigh risks; safety not established. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ketorolac can interact with several drug classes, requiring careful assessment before co‑administration.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, heparin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Lithium: elevated lithium levels, risk of toxicity. - Methotrexate: reduced clearance, potential toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion. - Diuretics: risk of renal function decline. - SSRIs or SNRIs: heightened bleeding tendency. - Beta‑blockers: may blunt antihypertensive effect.